COGT
Price
$4.37
Change
+$0.10 (+2.34%)
Updated
Apr 17 closing price
Capitalization
497.52M
25 days until earnings call
SLNO
Price
$69.98
Change
+$0.05 (+0.07%)
Updated
Apr 17 closing price
Capitalization
3.21B
25 days until earnings call
Ad is loading...

COGT vs SLNO

Header iconCOGT vs SLNO Comparison
Open Charts COGT vs SLNOBanner chart's image
Cogent Biosciences
Price$4.37
Change+$0.10 (+2.34%)
Volume$1.16M
Capitalization497.52M
Soleno Therapeutics
Price$69.98
Change+$0.05 (+0.07%)
Volume$1.24M
Capitalization3.21B
COGT vs SLNO Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. SLNO commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and SLNO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (COGT: $4.37 vs. SLNO: $69.98)
Brand notoriety: COGT and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 84% vs. SLNO: 87%
Market capitalization -- COGT: $497.52M vs. SLNO: $3.21B
COGT [@Biotechnology] is valued at $497.52M. SLNO’s [@Biotechnology] market capitalization is $3.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNO is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while SLNO’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • SLNO’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, COGT is a better buy in the short-term than SLNO.

Price Growth

COGT (@Biotechnology) experienced а +8.71% price change this week, while SLNO (@Biotechnology) price change was +11.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

SLNO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($3.21B) has a higher market cap than COGT($498M). SLNO YTD gains are higher at: 55.684 vs. COGT (-43.974). SLNO has higher annual earnings (EBITDA): -173.63M vs. COGT (-271.59M). SLNO (291M) and COGT (287M) have equal amount of cash in the bank . COGT has less debt than SLNO: COGT (17.5M) vs SLNO (52.8M). COGT (0) and SLNO (0) have equivalent revenues.
COGTSLNOCOGT / SLNO
Capitalization498M3.21B16%
EBITDA-271.59M-173.63M156%
Gain YTD-43.97455.684-79%
P/E RatioN/AN/A-
Revenue00-
Total Cash287M291M99%
Total Debt17.5M52.8M33%
FUNDAMENTALS RATINGS
COGT vs SLNO: Fundamental Ratings
COGT
SLNO
OUTLOOK RATING
1..100
5226
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
7852
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
9536
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (81) in the Miscellaneous industry is in the same range as SLNO (100) in the Medical Specialties industry. This means that COGT’s stock grew similarly to SLNO’s over the last 12 months.

SLNO's Profit vs Risk Rating (52) in the Medical Specialties industry is in the same range as COGT (78) in the Miscellaneous industry. This means that SLNO’s stock grew similarly to COGT’s over the last 12 months.

SLNO's SMR Rating (95) in the Medical Specialties industry is in the same range as COGT (96) in the Miscellaneous industry. This means that SLNO’s stock grew similarly to COGT’s over the last 12 months.

SLNO's Price Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for COGT (95) in the Miscellaneous industry. This means that SLNO’s stock grew somewhat faster than COGT’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as COGT (100) in the Miscellaneous industry. This means that SLNO’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTSLNO
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DESIX9.240.09
+0.98%
DFA Em Mkts Sustnby Cor 1 Instl
FSAEX10.94N/A
N/A
Fidelity Series All-Sector Equity
GPIGX12.23N/A
N/A
Guidepath® Growth and Income
INAAX15.71N/A
N/A
ALPS/Kotak India ESG A
CICAX52.65-0.20
-0.38%
American Funds Invmt Co of Amer 529A

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+2.34%
SPHDF - COGT
63%
Loosely correlated
N/A
ETNB - COGT
50%
Loosely correlated
+2.89%
ARWR - COGT
50%
Loosely correlated
-0.97%
XNCR - COGT
48%
Loosely correlated
+1.89%
CRNX - COGT
47%
Loosely correlated
+2.84%
More